The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke

NCT ID: NCT07347327

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2025-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial aims to study whether dual-target transcranial alternating current stimulation (tACS) applied to the auditory and motor brain region can improve repetition disorder in people with stroke, and to evaluate the safety of tACS. The main goals are to answer the following questions:

1. Can dual-tACS stimulation of the auditory and motor brain area improve repetition functions in people with aphasia after stroke?
2. Can it improve the integration of auditory information and speech motor control during communication?

Researchers will compare the effects of real tACS versus sham (placebo) stimulation to see if real stimulation leads to better outcomes in aphasia patients.

Participants will:

1. Receive one extra 20-minute session of either real or sham tACS each day for 10 days
2. Attend clinic visits before and after 10-days stimulation for clinical assessments(WAB) and fNIRS recording related brain activity

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aphasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

real group

dual-target tACS on auditory and motor brain area at a frequency of 8 Hz,with individualized current intensity, delivered for 20 minutes.

Group Type EXPERIMENTAL

speech training

Intervention Type BEHAVIORAL

speech training(especially repetition training) synchronized with tACS stimulation

real tACS

Intervention Type OTHER

dual-target tACS on auditory and motor brain area at a frequency of 8 Hz,with individualized current intensity, delivered for 20 minutes.

sham group

sham tACS except for turning down the current intensity to zero during the 20-minute period, all other parameters are identical to those in real group.

Group Type SHAM_COMPARATOR

speech training

Intervention Type BEHAVIORAL

speech training(especially repetition training) synchronized with tACS stimulation

sham tACS

Intervention Type OTHER

except for turning down the current intensity to zero during the 20-minute period, all other parameters are identical to those in real group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

speech training

speech training(especially repetition training) synchronized with tACS stimulation

Intervention Type BEHAVIORAL

real tACS

dual-target tACS on auditory and motor brain area at a frequency of 8 Hz,with individualized current intensity, delivered for 20 minutes.

Intervention Type OTHER

sham tACS

except for turning down the current intensity to zero during the 20-minute period, all other parameters are identical to those in real group.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meeting the diagnostic criteria for hemorrhagic or ischemic stroke in the Chinese Guidelines for the Prevention and Treatment of Cerebrovascular Diseases(2nd edition), with the first onset, single hemisphere stroke, and confirmed by CT or MRI,course of diease 1-6 months; ② Age ranging from 30 to 80 years old; ③ Native language is Mandarin or Cantonese; ④ Right-handed; ⑤ Diagnosed with aphasia by the Western Aphasia Battery (WAB) scale; ⑥ Able to cooperate in completing the speech repetition test; ⑦ Normal hearing.

Exclusion Criteria

① Currently receiving non-invasive brain stimulation treatment; ② Lesions involving the Broca or STG brain regions; ③ History of epilepsy, mental illness,or other neurological or mental disorders; ④ Any contraindications for transcranial electrical stimulation.
Minimum Eligible Age

30 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ke Dong, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ke Dong, MD

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Rehabilitation Medicine, The First Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Nos.82102648

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.